A Phase 2 Study of Hemay007 in Patients With Rheumatoid Arthritis

PHASE2CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

March 26, 2021

Primary Completion Date

June 22, 2023

Study Completion Date

June 22, 2023

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Hemay007 800 mg QD group

daily oral administrtion of Hemay007 800 mg QD for 12 weeks, 4 tablets of 200mg Hemay007 and 2 tablets of placebo.

DRUG

Hemay007 1200 mg QD group

daily oral administrtion of Hemay007 1200 mg QD for 12 weeks, 6 tablets of 200mg Hemay007.

DRUG

Hemay007 600 mg QD group

daily oral administrtion of Hemay007 600 mg QD for 12 weeks, 3 tablets of 200mg Hemay007 and 3 tablets of placebo.

DRUG

Hemay007 placebo group

daily oral administrtion of placebo for 12 weeks 6 tablets of placebo.

Trial Locations (41)

233000

The First Affiliated Hospital of Bengbu Medical College, Bengbu

337000

Pingxiang City People's Hospital, Pingxiang

510515

Southern Hospital of Southern Medical University, Guangzhou

530000

The First Affiliated Hospital of Guangxi Medical University, Nanning

570311

Hainan Provincial People's Hospital, Haikou

Unknown

Anhui Provincial Hospital, Hefei

The Second Affiliated Hospital of Anhui Medical University, Hefei

The First Affiliated Hospital of Xiamen University, Xiamen

Zhongshan Hospital Affiliated to Xiamen University, Xiamen

Sun Yat-sen University The Sixth Affiliated Hospital, Guangzhou

Affiliated Hospital of Guilin Medical College, Guilin

Liuzhou People's Hospital, Liuzhou

Hebei PetroChina Central Hospital, Langfang

Henan University of Science and Technology The First Affiliated Hospital, Luoyang

The First Affiliated Hospital of Nanyang Medical College, Nanyang

Xinxiang Central Hospital, Xinxiang

Loudi Central Hospital, Loudi

The First Affiliated Hospital of Shaoyang University, Shaoyang

The First Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology, Baotou

Affiliated Hospital of Inner Mongolia Medical University, Hohhot

The First People's Hospital of Jiujiang City, Jiujiang

Nanchang University The Second Affiliated Hospital, Nanchang

The First Affiliated Hospital of Nanchang University, Nanchang

Jilin University Sino-Japanese Friendship Hospital, Changchun

Jinzhou Central Hospital, Jinzhou

Panjin Liaoyou Gem Flower Hospital, Panjin

Ningxia Hui Autonomous Region People's Hospital, Yinchuan

Heze Municipal Hospital, Heze

Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan

Shandong University Qilu Hospital, Jinan

Jining First People's Hospital, Jining

Yantai Mountain Hospital, Yantai City, Yantai

Zaozhuang Municipal Hospital, Zaozhuang

Shanghai University of Traditional Chinese Medicine Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai

Changzhi Medical College Peace Hospital, Changzhi

Jinzhong First People's Hospital, Jinzhong

Guangyuan Central Hospital, Guangyuan

Affiliated Hospital of Southwest Medical University, Luzhou

Huzhou Third People's Hospital, Huzhou

Jinhua Central Hospital, Jinhua

Beijing Hospital, Beijing

All Listed Sponsors
lead

Tianjin Hemay Pharmaceutical Co., Ltd

INDUSTRY

NCT05247216 - A Phase 2 Study of Hemay007 in Patients With Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter